Health threat surfaces every so often, being epidemic, but also mushrooms
at times to pandemic. While preventative measures may be
biologic/metabolic but it may also be dispersive. In this regard the
Division focuses exclusively on dispersive preventative measures to
limit and mitigate transmissibility and contagion factors. These are
usually implemented through the founding of global corporations that
make available such control mechanisms that mitigate the dispersion of
the threat, while leaving the biologic preventative to the discipline
experts.
Then there is also the consequential adverse unintended consequences
that need be addressed. Such effects usually could be the result of
biologic preventative measures that cause additional post-infection
health issues. In this regard and in conjunction with the affiliate,
Aningba Medical Research Laboratory, (NV), the Division founds both
stationary and mobile regional subsidiary corporations that deliver
noninvasive treatments when possible. So, in all, the firm works on two
thrusts of corporations founding addressing Dispersive and Contagion
Infection Mitigation, and Non-Invasive Biologics Biophagisms
for eliminating diseases biologics
Dispersive and Contagion Infection Mitigation:
The current focus in this area of activity addresses the mitigation of
the corona virus of all strains through the use of destructive
bioincinerators. Accordingly, the Division is actively engaged on
founding SARS-CoV BioIncinerator Furniture Company that manufactures
types of furniture embodying an oxidizer of virus biologic constituent
chemicals, suitable for both home and corporate offices use, and that
operates by the continuous suction flow of ambient air through the
embodied oxidizer chamber, the net effect of which is the destructive
elimination of airborne virus biologics
NonInvasive Biologics-Biophagisms:
The activity in this area is prototype for manufacturing of engineering
systems for effecting the biophagism of biologics of diseases.
The goal is the provisioning of biophagism of diseases biologics of
body-systemic afflictions without regard to the specific nature of the
biologic. The prototype design utilizes non-invasive technologies.
Particularly about cancer, the object is
the phagism of the cancer collective cells and in particular the
defective gene biologic. The focus is the use of non-invasive radiations
fields to disrupt the structure of the cancer cell and thereby enable
the immune cells to recognize and destroy them
On the post endemic and pandemic derivative
effects of the corona-virus, the current focus is on the phagism of the remnants of the mRNA vaccines and limiting the spike concentration
in the body after the body immune system becomes unaware of it's
continued replication by the mRNA vaccine biologics.
Accordingly, the Division is actively
engaged on founding Biophagy Company that installs around the World facilities that
enable the induction of phagism metabolic reactions targeting specific
diseases biologics in patients such as to demolecularize the biologics. |